MU
42
4
ADBE
44
-2
TDC
55
-2
ABBV
53
3
GIS
54
4
VTR
35
3
SE
58
3
PGR
49
4
MA
48
-2
AES
49
3
ROP
33
-2
AMZN
55
4
CMG
51
-3
IR
44
4
HRL
42
-2
GOOG
67
2
PLD
35
5
PCAR
39
5
MAC
53
5
SIG
41
-2
MU
42
4
ADBE
44
-2
TDC
55
-2
ABBV
53
3
GIS
54
4
VTR
35
3
SE
58
3
PGR
49
4
MA
48
-2
AES
49
3
ROP
33
-2
AMZN
55
4
CMG
51
-3
IR
44
4
HRL
42
-2
GOOG
67
2
PLD
35
5
PCAR
39
5
MAC
53
5
SIG
41
-2
Financhill
Back

The Goldman Sachs Group Vs. Bright Minds Biosciences Industry Stock Comparison

Buy
63

GS
The Goldman Sachs Group

Last Price:
$580.02
Seasonality Move:
2.62%
Sell
45

DRUG
Bright Minds Biosciences

Last Price:
$39.35
Seasonality Move:
-32.13%
Buy
63
The Goldman Sachs Group (GS) is a Buy

Is The Goldman Sachs Group a Buy, Sell or Hold?

  • The current The Goldman Sachs Group [GS] share price is $580.13. The Score for GS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GS Stock Price Chart

What is The Goldman Sachs Group's stock price today?

  • The The Goldman Sachs Group share price today is $580.13
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing buying pressure, which is a positive indicator for future bullish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $39.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

GS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1 Sell
Relative Strength Index (14 RSI): 51.78 Buy
Chaikin Money Flow: 832791 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (569.26 - 599.18) Sell
Bollinger Bands (100): (491.61 - 580.55) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 51.96 Buy
Chaikin Money Flow: 6916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.23 - 42.31) Buy
Bollinger Bands (100): (3.23 - 44.21) Buy

GS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 576.53 Buy
20-day SMA: 579.44 Buy
50-day SMA: 574.1 Buy
200-day SMA: 492.61 Buy
8-day EMA: 575.95 Buy
20-day EMA: 578.01 Buy
50-day EMA: 567.97 Buy
200-day EMA: 500.19 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.78 Buy
20-day SMA: 38.81 Buy
50-day SMA: 41.79 Sell
200-day SMA: 12.42 Buy
8-day EMA: 39 Buy
20-day EMA: 39.09 Buy
50-day EMA: 36.04 Buy
200-day EMA: 18.43 Buy

The Goldman Sachs Group Earnings Growth & GS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.12 per share, and an increase next year of $5.50 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

The Goldman Sachs Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):